Rafik ElBeblawy
Rafik ElBeblawy publishes mostly in Oncology, Surgery and Radiology, Nuclear Medicine and Imaging, on topics such as Cancer Immunotherapy and Biomarkers, Lymphoma Diagnosis and Treatment and Monoclonal and Polyclonal Antibodies Research.
- World rank
- #6,019,303 of 7,710,434 ranked researchers
- Rank in United States
- #1,464,529 of 1,627,098
- Works
- 23
- Citations
- 24
- Citations per work
- 1.0
What does Rafik ElBeblawy research?
Rafik ElBeblawy's work is mostly in Medicine (46%), Biochemistry, Genetics and Molecular Biology (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1146.2%
- Medicine1146.2%
- Everything else1043.7%
- Life Sciences210.1%
- 1Oncology19% of their works
- 2Surgery13% of their works
- 3Radiology, Nuclear Medicine and Imaging7% of their works
- 4Neurology7% of their works
- 5Molecular Biology6% of their works
- 6Cancer Research4% of their works
Research topics
Which keywords describe Rafik ElBeblawy's research?
The keywords of their largest research topics: Neoadjuvant Therapy, Tumor Microenvironment, Chemotherapy, Preoperative Chemoradiotherapy, Classification, Fc Receptors, Immune Checkpoint Blockade and Lymphoma.
- Surgical Complications
- Prognostic Scoring System
- Pancreatic Cancer
- CDK4/6 Inhibitors
- Barrett's Esophagus
- Therapeutic Antibodies
- Lymphoma
- Fc Receptors
- Preoperative Chemoradiotherapy
- Tumor Microenvironment
- Neoadjuvant Therapy
- Chemotherapy
- Classification
- Immune Checkpoint Blockade
- PD-1 and PD-L1
- Adjuvant Chemotherapy
- Breast Cancer
- Esophageal Carcinoma
- Primary CNS Lymphoma
- Rectal Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Neoadjuvant Therapy63 topics
- Tumor Microenvironment52 topics
- Chemotherapy42 topics
- Preoperative Chemoradiotherapy42 topics
- Classification31 topic
- Fc Receptors31 topic
- Immune Checkpoint Blockade31 topic
- Lymphoma31 topic
- PD-1 and PD-L131 topic
- Therapeutic Antibodies31 topic
- Adjuvant Chemotherapy21 topic
- Barrett's Esophagus21 topic
- Breast Cancer21 topic
- CDK4/6 Inhibitors21 topic
- Esophageal Carcinoma21 topic
- Pancreatic Cancer21 topic
- Primary CNS Lymphoma21 topic
- Prognostic Scoring System21 topic
- Rectal Cancer21 topic
- Surgical Complications21 topic
Where does Rafik ElBeblawy work?
Rafik ElBeblawy's main affiliation in the publication record is Huntsville Hospital, United States.
How many publications and citations does Rafik ElBeblawy have?
OpenAlex counts 23 works and 24 citations for Rafik ElBeblawy, an h-index of 3, ranking #6,019,303 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Rafik ElBeblawy. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.